North Star Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $68.2K | Sell |
|
|||||
|
2025
Q2 | $97.6K | Buy |
|
|||||
|
2025
Q1 | $101K | Hold |
|
|||||
|
2024
Q4 | $95.6K | Hold |
|
|||||
|
2024
Q3 | $105K | Buy |
|
|||||
|
2024
Q2 | $95.8K | Hold |
|
|||||
|
2024
Q1 | $94.9K | Buy |
|
|||||
|
2023
Q4 | $85.1K | Hold |
|
|||||
|
2023
Q3 | $83.5K | Buy |
|
|||||
|
2023
Q2 | $82.3K | Sell |
|
|||||
|
2023
Q1 | $86.9K | Hold |
|
|||||
|
2022
Q4 | $87K | Hold |
|
|||||
|
2022
Q3 | $75K | Buy |
|
|||||
|
2022
Q2 | $75K | Hold |
|
|||||
|
2022
Q1 | $78K | Hold |
|
|||||
|
2021
Q4 | $75K | Buy |
|
|||||
|
2021
Q3 | $71K | Hold |
|
|||||
|
2021
Q2 | $71K | Buy |
|
|||||
|
2021
Q1 | $67K | Hold |
|
|||||
|
2020
Q4 | $65K | Buy |
|
|||||
|
2020
Q3 | $61K | Hold |
|
|||||
|
2020
Q2 | $61K | Buy |
|
|||||
|
2020
Q1 | $53K | Sell |
|
|||||
|
2019
Q4 | $81K | Sell |
|
|||||
|
2019
Q3 | $143K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $105K | Sell |
|
|||||
|
2018
Q4 | $143K | Buy |
|
|||||
|
2018
Q3 | $164K | Sell |
|
|||||
|
2018
Q2 | $159K | Sell |
|
|||||
|
2018
Q1 | $154K | Buy |
|
|||||
|
2017
Q4 | $30K | Sell |
|
|||||
|
2017
Q3 | $34K | Buy |
|
|||||
|
2017
Q2 | $35K | Buy |
|
|||||
|
2017
Q1 | $12K | Buy |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $54K | Buy |
|
|||||
|
2016
Q2 | $32K | Buy |
|
|||||
|
2016
Q1 | $20K | Buy |
|